Antipsychotic Drug Misuse Lands Johnson & Johnson on the Wrong End of Federal Suit

“In the federal suit, Johnson & Johnson is accused not just of promoting Risperdal for patients without psychosis but of providing kickbacks to Omnicare, a middleman that supplied drugs to nursing homes and advised doctors what to prescribe.  Last fall, Omnicare settled its part of the suit for $98 million.” The Boston Globe, Monday March … Continue reading

Rate this:

  • Books Written by Jon Hansen

Follow

Get every new post delivered to your Inbox.

Join 4,421 other followers